The board of directors of CVS Health (CVS) announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following discussions with Glenview Capital Management. With these four new directors, the board now comprises 16 members. In connection with the board appointments, CVS Health and Glenview entered into a confidentiality agreement under which Glenview has agreed to customary confidentiality, standstill and other provisions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Wells Fargo upgrades CVS Health to Overweight, ups price target to $66
- CVS Health upgraded to Overweight from Equal Weight at Wells Fargo
- CVS Health price target lowered to $58 from $68 at RBC Capital
- McKesson, Oracle among finalists looking to buy Veradigm, Axios reports
- CVS Health price target lowered to $71 from $75 at Barclays
Questions or Comments about the article? Write to editor@tipranks.com